Loading...
ABIVAX SA
AAVXF•PNK
Healthcare
Biotechnology
$68.60
$1.46(2.17%)
ABIVAX SA (AAVXF) Financial Performance & Income Statement Overview
Review ABIVAX SA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
0.00%
Net Income Growth
0.00%
Operating Cash Flow Growth
-58.62%
↓ 58.62%
Operating Margin
-1602.89%
↓ 1602.89%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-1633.08%
↓ 1633.08%
ROE
-211.00%
↓ 211.000%
ROIC
-153.91%
↓ 153.91%
ABIVAX SA (AAVXF) Income Statement & Financial Overview
Review ABIVAX SA's (AAVXF) income statement with detailed quarterly and annual figures.
Metric | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $6.79M | $1.12M | $1.12M | $1.12M |
Cost of Revenue | $0.00 | $378000.00 | $0.00 | $329000.00 |
Gross Profit | $6.79M | $744500.00 | $1.12M | $795000.00 |
Gross Profit Ratio | $1.00 | $0.66 | $1.00 | $0.71 |
R&D Expenses | $64.65M | $35.28M | $35.28M | $32.62M |
SG&A Expenses | $22.16M | $10.95M | $10.95M | $6.58M |
Operating Expenses | $86.78M | $46.17M | $47.80M | $39.21M |
Total Costs & Expenses | $86.78M | $46.17M | $47.80M | $39.53M |
Interest Income | $4.81M | $0.00 | $1.22M | $0.00 |
Interest Expense | $7.89M | $5.70M | $0.00 | $14.70M |
Depreciation & Amortization | $171000.00 | $65000.00 | $65000.00 | $329000.00 |
EBITDA | -$79.83M | -$45.02M | -$45.02M | -$18.60M |
EBITDA Ratio | -$11.76 | -$40.11 | -$40.11 | -$34.88 |
Operating Income | -$80.00M | -$45.05M | -$45.09M | -$39.53M |
Operating Income Ratio | -$11.79 | -$40.13 | -$40.17 | -$35.17 |
Other Income/Expenses (Net) | -$4.31M | -$2.85M | -$2.85M | -$14.65M |
Income Before Tax | -$84.30M | -$47.89M | -$47.89M | -$54.19M |
Income Before Tax Ratio | -$12.42 | -$42.67 | -$42.67 | -$48.21 |
Income Tax Expense | -$2.67M | -$2.26M | $0.00 | -$2.23M |
Net Income | -$81.64M | -$47.89M | -$47.89M | -$51.95M |
Net Income Ratio | -$12.03 | -$42.67 | -$42.67 | -$46.22 |
EPS | -$1.30 | -$0.95 | -$0.95 | -$1.45 |
Diluted EPS | -$1.30 | -$0.95 | -$0.95 | -$1.45 |
Weighted Avg Shares Outstanding | $62.92M | $50.23M | $50.23M | $35.90M |
Weighted Avg Shares Outstanding (Diluted) | $62.92M | $50.23M | $50.23M | $35.90M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan